Accueil Ernstrade Bourse Actualite Stock

plus500

Place: Copenhagen Stock Exchange

Affitech A/S, formerly Pharmexa A/S, is a Denmark-based biotechnology company engaged in the field of active immunotherapy and vaccines for the treatment of cancer, and serious chronic and infectious diseases. The Company has a number of patented technology platforms in immunotherapy and vaccination, as well as a portfolio of drug candidates at development stages from early research to clinical trials in patients. In May 2009, Pharmexa A/S merged with Affitech AS, a Norway-based human antibody therapeutics company, forming a combined company, Affitech A/S.  
 
 
 
 
 
 
 
 
 
 

 

Copyright   2010 Ernstrade.com